Skip to main content
Log in

Adapting the CHEERS Statement for Reporting Cost-Benefit Analysis

  • Letter to the Editor
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.


  1. Husereau D, Drummond M, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Pharmacoeconomics. 2013;31:361–7.

    Article  PubMed  Google Scholar 

  2. Sanghera S, Roberts T, Barton P, et al. LNG-IUS vs. usual medical treatment for menorrhagia: an economic evaluation alongside a randomised controlled trial. PLoS One. 2014;9(3):e91891. doi:10.1371/journal.pone.0091891.

    Article  PubMed Central  PubMed  Google Scholar 

  3. McIntosh E, Clarke PM, Frew EJ, et al. Applied methods of cost-benefit analysis in health care. Oxford: Oxford University Press; 2010.

    Google Scholar 

  4. Smith RD. Construction of the contingent valuation market in healthcare: a critical assessment. Health Econ. 2003;12:09–628.

    Article  Google Scholar 

Download references

Conflict of interest

The authors have no conflicts of interest that are directly related to this letter.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Tracy Roberts.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sanghera, S., Frew, E. & Roberts, T. Adapting the CHEERS Statement for Reporting Cost-Benefit Analysis. PharmacoEconomics 33, 533–534 (2015).

Download citation

  • Published:

  • Issue Date:

  • DOI: